Year Founded: 2008
Number of Employees: 400
Key Personnel: Nicholas Green, President and Chief Executive
Officer; David Long, Chief Financial Officer; Brian Hadfield, Chief
Manufacturing Officer; Dirk Alkema, Vice President, Technical
Operations; David N. Bell, Vice President, Drug Development
and Chief Scientific Officer
Contract manufacturing of biologics is more than having
superior technology—it’s having experienced people who
are passionate, responsive and committed to developing and
manufacturing your biotherapeutics to improve patient care. As
a fully integrated Contract Development and Manufacturing
Organization (CDMO), Therapure Biomanufacturing, a
division of Therapure Biopharma Inc., has the scientific and
technical expertise to successfully deliver at every stage of
product development (preclinical, clinical and commercial).
Our 136,000 ft2 ( 12,800m2) cGMP manufacturing facility
meets FDA, EMA and HPFB regulatory standards and includes
flexible clinical and commercial production suites.
• North America
• European Union
• Development: Cell Lines, Analytical Methods, Upstream
and Downstream Processes
• cGMP Biomanufacturing From a Variety of Biological
Sources Including Mammalian Cell Culture, Plasma,
• Aseptic Fill/Finish – Vials, Prefilled Syringes &
• Full Range of Quality Control Testing
a division of Therapure Biopharma, Inc.
2585 Meadowpine Blvd.
Mississauga, Ontario, L5N 8H9, Canada